Harmony Biosciences Holdings (HRMY)
US$ 39.0753.26%
Price Chart
Key Statistics
Market Cap
$ 2.06B
P/E Ratio
13.71
Revenue (TTM)
$ 744.85M
Volume
599.86K
52W High
$ 41.61
52W Low
$ 26.47
Dividend Yield
0.00%
Beta
0.82
Technicals
50-Day MA
31.8174
200-Day MA
34.61
52 Week High
41.61
52 Week Low
26.47
About HRMY
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United .
Employees
268
Headquarters
Plymouth Meeting, PA
CEO
Mr. Jeffrey S. Aronin
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg